CE: Appropriate Stewardship of New Antibiotics in the Era of Antimicrobial Resistance

Pharmacy Times Health Systems Edition, July 2020, Volume 9, Issue 4

Antimicrobial resistance has become a serious public health concern because of increased health care costs and significant morbidity and mortality.

THIS ACTIVITY IS SUPPORTED BY AN EDUCATIONAL GRANT FROM MERCK SHARP & DOHME CORP.

EDUCATIONAL OBJECTIVES

At the completion of this activity, the participant will be able to:

• Explore the threat of global antimicrobial resistance and its impact on health systems and patient outcomes

• Differentiate between newly approved treatment options for carbapenem-resistant Enterobacterales pathogens

• Examine targeted strategies for an effective antimicrobial stewardship program within an institution

FACULTY

Liza Vaezi, MSc, PharmD, BCPS-AQID, BCIDP

Infectious Diseases and Critical Care Pharmacist

Antimicrobial Stewardship Program, Co-Director, Virginia Mason Medical Center

Clinical Associate Professor, University of Washington Affiliation, Seattle, Washington

TARGET AUDIENCE: Pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: July 17, 2020

EXPIRATION DATE: July 17, 2021

ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.